Seer, Inc. (NASDAQ:SEER) Short Interest Down 34.8% in June

Seer, Inc. (NASDAQ:SEER) saw a large decline in short interest in June. As of June 15th, there was short interest totaling 191,696 shares, a decline of 34.8% from the May 31st total of 293,816 shares. Based on an average trading volume of 127,131 shares, the short-interest ratio is currently 1.5 days. Approximately 0.4% of the company’s stock are sold short.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on SEER shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research report on Tuesday, April 21st. TD Cowen raised Seer to a “strong-buy” rating in a report on Monday, April 13th. Finally, Canaccord Genuity Group began coverage on Seer in a report on Monday, May 4th. They issued a “buy” rating and a $4.00 price objective on the stock. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Seer currently has a consensus rating of “Buy” and an average target price of $4.00.

Hedge Funds Weigh In On Seer

Hedge funds have recently modified their holdings of the business. Occudo Quantitative Strategies LP acquired a new position in shares of Seer in the 2nd quarter valued at $25,000. Marshall Wace LLP purchased a new position in Seer during the 4th quarter worth $85,000. Quadrature Capital Ltd acquired a new position in Seer in the fourth quarter valued at $101,000. Barclays PLC raised its holdings in shares of Seer by 685.0% in the fourth quarter. Barclays PLC now owns 60,717 shares of the company’s stock valued at $111,000 after buying an additional 52,982 shares during the last quarter. Finally, Corient Private Wealth LLC purchased a new stake in shares of Seer in the fourth quarter valued at about $116,000. 75.20% of the stock is currently owned by hedge funds and other institutional investors.

Seer Price Performance

Shares of SEER opened at $1.63 on Thursday. Seer has a 1-year low of $1.62 and a 1-year high of $2.41. The stock has a market cap of $89.62 million, a PE ratio of -1.31 and a beta of 1.59. The firm has a fifty day moving average price of $1.80 and a 200 day moving average price of $1.83.

Seer (NASDAQ:SEER) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). The company had revenue of $2.79 million for the quarter, compared to analyst estimates of $3.60 million. Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.